Morgan Williams - Cizzle Biotechnology Head Observer

CIZ Stock   1.85  0.15  8.82%   

Executive

Morgan Williams is Head Observer of Cizzle Biotechnology Holdings
Address 60 Gracechurch Street, London, United Kingdom, EC3V 0HR
Phone44 20 3934 6630
Webhttps://www.cizzlebiotechnology.com

Cizzle Biotechnology Management Efficiency

The company has return on total asset (ROA) of (0.3172) % which means that it has lost $0.3172 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5781) %, meaning that it generated substantial loss on money invested by shareholders. Cizzle Biotechnology's management efficiency ratios could be used to measure how well Cizzle Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cizzle Biotechnology's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 1.5 M, whereas Other Current Assets are forecasted to decline to about 116.3 K.

Similar Executives

Showing other executives

EXECUTIVE Age

Adam ChesterCaledonia Mining
N/A
LLB LLBFirst Majestic Silver
N/A
Steve HoldenGamma Communications PLC
N/A
Connie BAFirst Majestic Silver
N/A
Chris WadeGamma Communications PLC
N/A
Gonzalo MercadoFirst Majestic Silver
N/A
James BushellGamma Communications PLC
N/A
David MacfarlaneGamma Communications PLC
57
Camilla HorsfallCaledonia Mining
N/A
Andy MorrisGamma Communications PLC
53
Marco BiscegliaCairo Communication SpA
N/A
Andrew TaylorGamma Communications PLC
55
Lauren McManusGamma Communications PLC
N/A
Daryl PileGamma Communications PLC
N/A
Chris BradfordGamma Communications PLC
N/A
Matt DaviesGamma Communications PLC
N/A
BCL LLBFirst Majestic Silver
N/A
Samantha RussellGamma Communications PLC
N/A
Jill AriasFirst Majestic Silver
N/A
Steven HolmesFirst Majestic Silver
N/A
Todd MBAFirst Majestic Silver
N/A
Cizzle Biotechnology Holdings (CIZ) is traded on London Exchange in UK and employs 4 people. Cizzle Biotechnology is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Cizzle Biotechnology Leadership Team

Elected by the shareholders, the Cizzle Biotechnology's board of directors comprises two types of representatives: Cizzle Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cizzle. The board's role is to monitor Cizzle Biotechnology's management team and ensure that shareholders' interests are well served. Cizzle Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cizzle Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Allan Syms, Executive Chairman
Pr Coverley, Founder Director
Nigel Lee, Finance Director
Morgan Williams, Head Observer

Cizzle Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cizzle Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cizzle Stock

Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.